Stocksigma LogoStocksigma Logo

Brawn Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 562 (+15.0% YoY | -7.5% QoQ) ■ EBITDA: -8.0 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -1.4 (Profit to Loss YoY | Profit to

Brawn Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Brawn Biotech Ltd · Outcome · 05 Nov 2026, 8:02 pm

Brawn Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 562 (+15.0% YoY | -7.5% QoQ) ■ EBITDA: -8.0 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -1.4 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: 3.0 (-57.6% YoY | -80.4% QoQ) ■ EPS (INR): 0.12 (-52.0% YoY | -76.9% QoQ)

Original exchange filing (PDF)

More announcements from Brawn Biotech Ltd

All Brawn Biotech Ltd announcements